映恩生物-B:股份将调入恒生综合指数成份股及港股通
Core Viewpoint - The announcement indicates that Ying'en Bio-B will be included in the Hang Seng Composite Index starting September 8, 2025, reflecting strong recognition of the company's performance and value by the capital market [1] Group 1 - The inclusion in the Hang Seng Composite Index is expected to expand the investor base for the company [1] - The move is anticipated to increase the trading liquidity of the company's shares [1]